LRRK2 and Parkinson disease: Additionally, markers of OS (8-hydroxy-2′-deoxyguanosine and 8-isoprostane) are increased with a corresponding decrease in total antioxidant content in the cerebrospinal fluid of healthy individuals with PD-associated LRRK2-G2019S mutation [90].